Seres Therapeutics Inc (MCRB) stock is down -84.11% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MCRB stock a score of 32 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. MCRB's rank also includes a short-term technical score of 5. MCRB has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on MCRB!